Industry deals

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

agbiopro

Aug 19, 2020
0 min

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

21 views0 comments

GentiBio Launches with $20 Million Seed Funding from Novartis and Others

agbiopro

Aug 19, 2020
0 min

GentiBio Launches with $20 Million Seed Funding from Novartis and Others

8 views0 comments

Kymera Therapeutics Unveils IPO Pitch for Protein Degradation

agbiopro

Aug 3, 2020
0 min

Kymera Therapeutics Unveils IPO Pitch for Protein Degradation

10 views0 comments

Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership

agbiopro

Aug 3, 2020
0 min

Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership

7 views0 comments

C4 Therapeutics Adds $170M to Test Protein Degraders in the Clinic

agbiopro

Jun 30, 2020
0 min

C4 Therapeutics Adds $170M to Test Protein Degraders in the Clinic

3 views0 comments

Cambridge biotech launches with $50M to target 'junk DNA'

agbiopro

Apr 29, 2020
0 min

Cambridge biotech launches with $50M to target 'junk DNA'

11 views0 comments

With $45M Nurix Deal, Gilead Enters Crowded Protein Degradation Field

agbiopro

Jun 20, 2019
0 min

With $45M Nurix Deal, Gilead Enters Crowded Protein Degradation Field

9 views0 comments

InFarm Joins Vertical Farming Pantheon With Titanic $100m Series B

agbiopro

Jun 18, 2019
0 min

InFarm Joins Vertical Farming Pantheon With Titanic $100m Series B

5 views0 comments

UK Immune Cell Therapy Biotech Founded with €40M Series A

agbiopro

May 30, 2019
1 min

UK Immune Cell Therapy Biotech Founded with €40M Series A

Quell Therapeutics, a London-based biotech developing immune cell therapies to target transplant rejection and autoimmune and...

7 views0 comments

Vertex pays Kymera $70M upfront to discover protein degradation drugs

agbiopro

May 18, 2019
0 min

Vertex pays Kymera $70M upfront to discover protein degradation drugs

4 views0 comments

Servier launches U.S. cancer business with plans to double headcount in next 5 years

agbiopro

May 10, 2019
0 min

Servier launches U.S. cancer business with plans to double headcount in next 5 years

2 views0 comments

Ninjacart Raises $89m from Tiger Global in India’s Largest-Ever Farm Tech Deal

agbiopro

May 2, 2019
0 min

Ninjacart Raises $89m from Tiger Global in India’s Largest-Ever Farm Tech Deal

1 view0 comments

AbbVie hands Voyager a mega-billions gene therapy deal, with $310M in near-term cash

agbiopro

Apr 28, 2019
0 min

AbbVie hands Voyager a mega-billions gene therapy deal, with $310M in near-term cash

2 views0 comments

AbbVie puts up $105M for Tizona's preclinical I/O drug

agbiopro

Apr 23, 2019
0 min

AbbVie puts up $105M for Tizona's preclinical I/O drug

5 views0 comments

The top 20 preclinical biotech deals ranked by cash upfront reveals 3 big players — and some major l

agbiopro

Apr 23, 2019
0 min

The top 20 preclinical biotech deals ranked by cash upfront reveals 3 big players — and some major l

6 views0 comments

agbiopro

Apr 21, 2019
1 min

A 1.2 Bilion Gene Therapy Deal

Less than a month after Thermo Fisher unveiled a $1.7 billion deal to swallow Brammer Bio — a company that does contract viral vector...

7 views0 comments

The Bristol-Celgene merger is approved. Here are 8 challenges ahead

agbiopro

Apr 14, 2019
0 min

The Bristol-Celgene merger is approved. Here are 8 challenges ahead

7 views0 comments

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

GentiBio Launches with $20 Million Seed Funding from Novartis and Others

Kymera Therapeutics Unveils IPO Pitch for Protein Degradation

Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership

C4 Therapeutics Adds $170M to Test Protein Degraders in the Clinic

Cambridge biotech launches with $50M to target 'junk DNA'

With $45M Nurix Deal, Gilead Enters Crowded Protein Degradation Field

InFarm Joins Vertical Farming Pantheon With Titanic $100m Series B

UK Immune Cell Therapy Biotech Founded with €40M Series A

Vertex pays Kymera $70M upfront to discover protein degradation drugs

Servier launches U.S. cancer business with plans to double headcount in next 5 years

Ninjacart Raises $89m from Tiger Global in India’s Largest-Ever Farm Tech Deal

AbbVie hands Voyager a mega-billions gene therapy deal, with $310M in near-term cash

AbbVie puts up $105M for Tizona's preclinical I/O drug

The top 20 preclinical biotech deals ranked by cash upfront reveals 3 big players — and some major l

A 1.2 Bilion Gene Therapy Deal

The Bristol-Celgene merger is approved. Here are 8 challenges ahead

Agbiopro

Send Us a Message